Guidelines and definitions for research on epithelial-mesenchymal transition
Open accessThe DOI matches its Crossref record; 138 of the 139 references it cites were found in a registry or an index.
Abstract
Epithelial–mesenchymal transition (EMT) encompasses dynamic changes in cellular organization from epithelial to mesenchymal phenotypes, which leads to functional changes in cell migration and invasion. EMT occurs in a diverse range of physiological and pathological conditions and is driven by a conserved set of inducing signals, transcriptional regulators and downstream effectors. With over 5,700 publications indexed by Web of Science in 2019 alone, research on EMT is expanding rapidly. This growing interest warrants the need for a consensus among researchers when referring to and undertaking research on EMT. This Consensus Statement, mediated by ‘the EMT International Association’ (TEMTIA), is the outcome of a 2-year-long discussion among EMT researchers and aims to both clarify the nomenclature and provide definitions and guidelines for EMT research in future publications. We trust that these guidelines will help to reduce misunderstanding and misinterpretation of research data generated in various experimental models and to promote cross-disciplinary collaboration to identify and address key open questions in this research field. While recognizing the importance of maintaining diversity in experimental approaches and conceptual frameworks, we emphasize that lasting contributions of EMT research to increasing our understanding of developmental processes and combatting cancer and other diseases depend on the adoption of a unified terminology to describe EMT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“consistent with enhanced paracrine signaling from increased numbers of senescent neighbors and with established features of epithelial aging.23,25,32–35”
From SenCat: Cataloging human cell senescence through multi-omic profiling of multiple senescent primary cell types (2026) · cites this paper as [34]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Epithelial-to-mesenchymal transition (EMT) is another potential mechanism of both intrinsic and acquired resistance to KRASG12C inhibitors.”
From The current state of the art and future trends in RAS-targeted cancer therapies (2022) · cites this paper as [114]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Expression of canonical EMT transcription factors, including Snai1/2, Zeb1/2, and Twist1, is observed in both contexts77.”
From Cell diversity and plasticity during atrioventricular heart valve EMTs (2023) · cites this paper as [77]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“A major challenge in the field has been to reliably identify senescent cells in tissues and organs.23,25,32–35”
From SenCat: Cataloging human cell senescence through multi-omic profiling of multiple senescent primary cell types (2026) · cites this paper as [34]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nieto, M. A., Huang, R. Y.-J., Jackson, R. A., & Thiery, J. P. (2016) · Cell · doi:10.1016/j.cell.2016.06.028 · Cited by 4,492
Self-citationNew insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
Dongre, A., & Weinberg, R. A. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0080-4 · Cited by 3,876
Self-citationTwist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,855
Self-citationCano, A., Pérez-Moreno, M. A., Rodrigo, I., Locascio, A., Blanco, M. J., del Barrio, M. G., Portillo, F., & Nieto, M. A. (2000) · Nature Cell Biology · doi:10.1038/35000025 · Cited by 3,668
Self-citationEmerging Biological Principles of Metastasis
Lambert, A. W., Pattabiraman, D. R., & Weinberg, R. A. (2017) · Cell · doi:10.1016/j.cell.2016.11.037 · Cited by 3,067
Self-citationBatlle, E., Sancho, E., Francí, C., Domínguez, D., Monfar, M., Baulida, J., & García de Herreros, A. (2000) · Nature Cell Biology · doi:10.1038/35000034 · Cited by 2,666
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
Yu, M., Bardia, A., Wittner, B. S., Stott, S. L., Smas, M. E., Ting, D. T., Isakoff, S. J., Ciciliano, J. C., Wells, M. N., Shah, A. M., et al. (2013) · Science · doi:10.1126/science.1228522 · Cited by 2,476
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
Zeisberg, E. M., Tarnavski, O., Zeisberg, M., Dorfman, A. L., McMullen, J. R., Gustafsson, E., Chandraker, A., Yuan, X., Pu, W. T., Roberts, A. B., et al. (2007) · Nature Medicine · doi:10.1038/nm1613 · Cited by 2,222
Self-citationZheng, X., Carstens, J. L., Kim, J., Scheible, M., Kaye, J., Sugimoto, H., Wu, C.-C., LeBleu, V. S., & Kalluri, R. (2015) · Nature · doi:10.1038/nature16064 · Cited by 2,032
Self-citationFischer, K. R., Durrans, A., Lee, S., Sheng, J., Li, F., Wong, S. T. C., Choi, H., El Rayes, T., Ryu, S., Troeger, J., et al. (2015) · Nature · doi:10.1038/nature15748 · Cited by 1,791
Research works printed but not linked: 1
- Hay, E. D. in Epithelial–Mesenchymal Interactions: 18th Hahnemann Symposium (eds R. Fleischmajer & Billingham, R. E.) 31–35 (Williams and Wilkins, 1968).
Cited by
Items 101–200 of 1,001
Jamming and arrest of cell motion in biological tissues
Lawson-Keister, E., & Manning, M. L. (2021) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2021.07.011 · Cited by 109
“Similarly, in cancers, the epithelial to mesenchymal transition (EMT) causes epithelial cells to become less confluent and more migratory [61, 68].”
BackgroundLing, S., Zhang, X., Dai, Y., Jiang, Z., Zhou, X., Lu, S., Qian, X., Liu, J., Selfjord, N., Şatır, T. M., et al. (2025) · Nature Nanotechnology · doi:10.1038/s41565-024-01851-7 · Cited by 109
“Using scRNA-seq, we also defined the cell state transition to which gene editing may at least partially contribute by detecting an evident population of RPE cells with EMT characteristics 56 .”
Self-citationHypoxia-driven intratumor heterogeneity and immune evasion
Terry, S., Engelsen, A. S. T., Buart, S., El‐Sayed, W., Venkatesh, G. H., & Chouaïb, S. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.07.004 · Cited by 107
Establishing a conceptual framework for holistic cell states and state transitions
Rafelski, S. M., & Theriot, J. A. (2024) · Cell · doi:10.1016/j.cell.2024.04.035 · Cited by 91
Thirant, C., Peltier, A., Durand, S., Kramdi, A., Louis‐Brennetot, C., Pierre‐Eugène, C., Gautier, M., Costa, A., Grelier, A., Zaïdi, S., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38239-5 · Cited by 106
Wang, W., Douglas, D. L., Zhang, J., Kumari, S., Enuameh, M. S., Dai, Y., Wallace, C. T., Watkins, S. C., Shu, W., & Xing, J. (2020) · Science Advances · doi:10.1126/sciadv.aba9319 · Cited by 105
Self-citationAlternative splicing in EMT and TGF-β signaling during cancer progression
Zhang, Y. E., & Stuelten, C. H. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.04.001 · Cited by 106
Are cell jamming and unjamming essential in tissue development?
Atia, L., Fredberg, J. J., Gov, N. S., & Pegoraro, A. F. (2021) · Cells and Development · doi:10.1016/j.cdev.2021.203727 · Cited by 110
Roles of Podoplanin in Malignant Progression of Tumor
Suzuki, H., Kaneko, M. K., & Kato, Y. (2022) · Cells · doi:10.3390/cells11030575 · Cited by 105
“During EMT, changes occur in gene expression, including EMT transcriptional factors (EMT–TFs) and their targets, as well as epigenetic regulation, resulting in the suppression of these epithelial characteristics and the acquisition of mesenchymal characteristics [102,103].”
BackgroundDissecting the Role of AXL in Cancer Immune Escape and Resistance to Immune Checkpoint Inhibition
Engelsen, A. S. T., Lotsberg, M. L., Khouzam, R. A., Thiery, J. P., Lorens, J. B., Chouaïb, S., & Terry, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.869676 · Cited by 104
“serves to generate intermediate EMT phenotypes (also known as intermediate E/M cells or hybrid cells) (143).”
BackgroundSelf-citationFascin actin-bundling protein 1 in human cancer: Promising biomarker or therapeutic target?
Liu, H., Zhang, Y., Li, L., Cao, J., Guo, Y., Wu, Y., & Gao, W. (2021) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2020.12.014 · Cited by 103
Role of Leptin and Adiponectin in Carcinogenesis
Bocian, A., Malczewska, A., & Kos‐Kudła, B. (2023) · Cancers · doi:10.3390/cancers15174250 · Cited by 102
Tissue architecture in tumor initiation and progression
Almagro, J., Messal, H. A., Elósegui-Artola, A., van Rheenen, J., & Behrens, A. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.02.007 · Cited by 101
Epithelial cell plasticity drives endoderm formation during gastrulation
Scheibner, K., Schirge, S., Burtscher, I., Büttner, M., Sterr, M., Yang, D., Böttcher, A., Ansarullah, M., Irmler, M., Beckers, J., et al. (2021) · Nature Cell Biology · doi:10.1038/s41556-021-00694-x · Cited by 100
Chen, H., Wu, L., Wang, T., Zhang, F., Song, J., Fu, J., Kong, X., & Shi, J. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.06.025 · Cited by 100
Nie, F., Sun, X., Sun, J., Zhang, J., & Wang, Y. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02593-8 · Cited by 99
An Update on the Effectiveness of Probiotics in the Prevention and Treatment of Cancer
Sankarapandian, V., Maran, B. A. V., Rajendran, R. L., Jogalekar, M. P., Sridharan, G., Krishnamoorthy, R., Gangadaran, P., & Ahn, B. (2022) · Life · doi:10.3390/life12010059 · Cited by 98
van Vliet, N., Quiceno-Mesa, M. P., Cruz, D., Téllez, L., Martins, C. F., Haiden, E., Oliveira, M. R., Adams, C., Morsello, C., Valencia, L., et al. (2015) · Ethnobiology and Conservation · doi:10.15451/ec2015-7-4.6-1-12 · Cited by 99
Extracellular matrix stiffness regulates colorectal cancer progression via HSF4
Wang, K., Ning, S., Zhang, S., Jiang, M., Huang, Y., Pei, H., Li, M., & Tan, F. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03297-8 · Cited by 97
Tissue fluidification promotes a cGAS–STING cytosolic DNA response in invasive breast cancer
Frittoli, E., Palamidessi, A., Iannelli, F., Zanardi, F., Villa, S., Barzaghi, L., Abdo, H., Cancila, V., Beznoussenko, G. V., Chiara, G. D., et al. (2022) · Nature Materials · doi:10.1038/s41563-022-01431-x · Cited by 96
Liaghat, M., Ferdousmakan, S., Mortazavi, S. H., Yahyazadeh, S., Irani, A., Banihashemi, S., Asl, F. S. S., Akbari, A., Farzam, F., Aziziyan, F., et al. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01957-4 · Cited by 97
Komorowska, D., Radzik, T., Kalenik, S., & Rodacka, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810627 · Cited by 95
“ETM is associated with enhancement resistance to radiotherapy and poor prognosis in multiple types of malignant tumors [4].”
BackgroundPulmonary inflammation and fibroblast immunoregulation: from bench to bedside
Ghonim, M. A., Boyd, D. F., Flerlage, T., & Thomas, P. G. (2023) · Journal of Clinical Investigation · doi:10.1172/jci170499 · Cited by 95
“There is a wide range of EMT phenotypic presentations, where changes in gene expression and posttranslational regulatory mechanisms take place to enable induction of fibroblast-like cytoarchitecture and migratory capability (1).”
BackgroundOrtega, Á., Vera, I., Díaz, M. I., Navarro, C., Rojas, M., Torres, W., Parra, H., Salazar, J. J., Sanctis, J. B. D., & Bermúdez, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010430 · Cited by 95
“However, in turn both are indispensable for EMT and required for MET [78,79].”
BackgroundInfluentialAdachi, Y., Kimura, R., Hirade, K., Yanase, S., Nishioka, Y., Kasuga, N., Yamaguchi, R., & Ebi, H. (2023) · Nature Cancer · doi:10.1038/s43018-023-00575-2 · Cited by 93
Epithelial-to-Mesenchymal Transition in Fibrosis: Concepts and Targeting Strategies
Lovisa, S. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.737570 · Cited by 94
Epithelial–Mesenchymal Plasticity in Tumor Immune Evasion
Mullins, R. D. Z., Pal, A., Barrett, T. F., Neal, M. E. H., & Puram, S. V. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-4370 · Cited by 94
Gaikwad, A. V., Eapen, M. S., McAlinden, K. D., Chia, C., Larby, J., Myers, S., Dey, S., Haug, G., Markos, J., Glanville, A. R., et al. (2020) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2020.1795832 · Cited by 91
Drug resistance in glioblastoma: are persisters the key to therapy?
Oliver, L., Lalier-Bretaudeau, L., Salaud, C., Heymann, D., Cartron, P., & Vallette, F. M. (2020) · Cancer Drug Resistance · doi:10.20517/cdr.2020.29 · Cited by 91
“Most common cellular mechanisms Several excellent reviews have recently described the current mechanisms of resistance in cancers([2-8]).”
BackgroundKang, E., Seo, J., Yoon, H., & Cho, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073591 · Cited by 90
“Abbreviations ATM Ataxia–telangiectasia mutated kinase BLBCs Basal-like breast cancer cells β-TrCP Beta-transducin repeat-containing protein CBP CREB-binding protein CDK2 Cyclin-dependent kinase 2 CSN5 COP9 signalosome subunit 5 CtBP C-terminal binding protein CZF C-terminal zinc finger DUBs Deubiquitinating enzymes E…”
BackgroundInfluentialCarstens, J. L., Yang, S., de Sampaio, P. C., Zheng, X., Barua, S., McAndrews, K. M., Rao, A. U. K., Burks, J. K., Rhim, A. D., & Kalluri, R. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108990 · Cited by 91
Self-citationAdaptation of the Golgi Apparatus in Cancer Cell Invasion and Metastasis
Bui, S., Mejia, I., Díaz, B., & Wang, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.806482 · Cited by 83
“However, as mentioned earlier, EMT in cancer is not completely resolved and cancer cells often retain a mixture of mesenchymal and epithelial traits which confer these cells with the necessary plasticity to adapt to changing environments (Yang et al., 2020).”
BackgroundThe Synergistic Cooperation between TGF-β and Hypoxia in Cancer and Fibrosis
Mallikarjuna, P., Zhou, Y., & Landström, M. (2022) · Biomolecules · doi:10.3390/biom12050635 · Cited by 90
“The TGF-β stimulation of epithelial cells leads to their transdifferentiation to acquire a mesenchymal phenotype and to transform them to become mobile and invasive in a process called EMT [23,24].”
BackgroundCellular and molecular mechanisms of plasticity in cancer
Torborg, S. R., Li, Z., Chan, J. E., & Tammela, T. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.04.007 · Cited by 93
Targeting Ferroptosis Pathway to Combat Therapy Resistance and Metastasis of Cancer
Liu, X., Zhang, Y., Wu, X., Xu, F., Ma, H., Wu, M., & Xia, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.909821 · Cited by 91
Neuraminidase 1 promotes renal fibrosis development in male mice
Chen, Q., Liu, K., Shi, N., Ma, G., Wang, P., Xie, H.-M., Jin, S.-J., Wei, T., Yu, X.-Y., Wang, Y., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37450-8 · Cited by 89
TGF-β and RAS jointly unmask primed enhancers to drive metastasis
Lee, J. H., Rivera, F. J. S., He, L. Y., Basnet, H., Chen, F., Spina, E., Li, L., Torner, C., Chan, J. E., Yarlagadda, D. V. K., et al. (2024) · Cell · doi:10.1016/j.cell.2024.08.014 · Cited by 89
Self-citationGREM1 is required to maintain cellular heterogeneity in pancreatic cancer
Lan, L., Evan, T., Li, H., Hussain, A., Ruiz, E. J., Thin, M. Z., Ferreira, R. M. M., Hari, P. S., Riising, E. M., Zen, Y., et al. (2022) · Nature · doi:10.1038/s41586-022-04888-7 · Cited by 89
Promising role of protein arginine methyltransferases in overcoming anti-cancer drug resistance
Zhu, Y., Xia, T., Chen, D.-Q., Xiong, X., Shi, L., Zuo, Y., Xiao, H., & Liu, L. (2023) · Drug Resistance Updates · doi:10.1016/j.drup.2023.101016 · Cited by 88
Eslami‐S, Z., Cortés‐Hernández, L. E., Thomas, F., Pantel, K., & Alix‐Panabières, C. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01819-1 · Cited by 87
“The term “partial EMT” has also been suggested to better express this balance [54].”
BackgroundEngineering micro oxygen factories to slow tumour progression via hyperoxic microenvironments
Wang, W., Zheng, H., Jiang, J., Li, Z., Jiang, D., Shi, X., Wang, H., Jiang, J., Xie, Q., Gao, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32066-w · Cited by 87
Cofilin: A Promising Protein Implicated in Cancer Metastasis and Apoptosis
Xu, J., Huang, Y., Zhao, J., Wu, L., Qi, Q., Liu, Y., Li, G., Li, J., Liu, H., & Wu, H. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.599065 · Cited by 88
Ge, C., Zhang, S., Mu, H., Shaojun, Z., Tan, Z., Huang, X., Chen, X., Zou, J., Zhu, Y., Dong, F., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.774957 · Cited by 87
Aouad, P., Zhang, Y., Martino, F. D., Stibolt, C., Ali, S., Ambrosini, G., Mani, S. A., Maggs, K., Quinn, H. M., Sflomos, G., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32523-6 · Cited by 86
“7m-Clover-Geminin(1-110)-IRESmKO2-Cdt(30-120)was a gift fromMichael Lin (Addgene_83841; http:// n2t.”
BackgroundSelf-citationGoyette, M.-A., & Côté, J. (2022) · Cancers · doi:10.3390/cancers14030466 · Cited by 85
“EMT affords several advantages to tumor cells by enhancing cell invasion, apoptosis resistance and stem-like characteristics at the expense of proliferation, therefore contributing to tumor progression and therapy resistance [49].”
BackgroundMicrofluidics meets 3D cancer cell migration
Mehta, P., Rahman, Z., ten Dijke, P., & Boukany, P. E. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.03.006 · Cited by 85
Singh, L., Nair, L. S., Kumar, D., Arora, M. K., Bajaj, S., Gadewar, M. M., Mishra, S. S., Rath, S. K., Dubey, A. K., Kaithwas, G., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1034205 · Cited by 85
“Integrin proteins linked to cytokeratin inside the cytoplasm help epithelial cells adhere to the basement membrane (53).”
BackgroundKhatib, A., Solaimuthu, B., Yosef, M. B., Rmaileh, A. A., Tanna, M., Oren, G., Frisch, M. S., Axelrod, J. H., Lichtenstein, M., & Shaul, Y. D. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2010275117 · Cited by 85
Ghahhari, N. M., Sznurkowska, M. K., Hulo, N., Bernasconi, L., Aceto, N., & Picard, D. (2022) · Nature Communications · doi:10.1038/s41467-022-29723-5 · Cited by 84
Giacomelli, C., Piccarducci, R., Marchetti, L., Romei, C., & Martini, C. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114812 · Cited by 85
Immunosuppressive Traits of the Hybrid Epithelial/Mesenchymal Phenotype
Sahoo, S., Nayak, S. P., Hari, K., Purkait, P., Mandal, S., Kishore, A., Levine, H., & Jolly, M. K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.797261 · Cited by 83
Self-citationPathogenesis of periodontitis – A potential role for epithelial-mesenchymal transition
Saliem, S. S., Bede, S. Y. H., Cooper, P. R., Abdulkareem, A. A., Milward, M. R., & Abdullah, B. H. (2022) · Japanese Dental Science Review · doi:10.1016/j.jdsr.2022.09.001 · Cited by 84
“Recently the case definition of EMT was extensively reviewed by Yang and coauthors [16] and they outlined a set of criteria to enable diagnosis of cells undergoing EMT.”
BackgroundEMT and cancer: what clinicians should know
Thompson, E. W., Redfern, A. D., Brabletz, S., Berx, G., Agarwal, V., Ganesh, K., Huang, R. Y., Ishay-Ronen, D., Savagner, P., Sheng, G., et al. (2025) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-025-01058-2 · Cited by 83
“In some scenarios, the roles of EMT in malignancy oppose each other, for example, the apparent requirement of reverse transition (MET) for metastatic competence after EMT has promoted initial invasion, therapy resistance and immune suppression 1,3,5 .”
Self-citationIron-Sensitive Prodrugs That Trigger Active Ferroptosis in Drug-Tolerant Pancreatic Cancer Cells
Antoszczak, M., Müller, S., Cañeque, T., Colombeau, L., Dusetti, N., Santofimia‐Castaño, P., Gaillet, C., Puisieux, A., Iovanna, J., & Rodriguez, R. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c03973 · Cited by 82
Self-citationBłaszczak, E., Miziak, P. A., Odrzywolski, A., Baran, M. T., Gumbarewicz, E., & Stepulak, A. (2025) · Cancers · doi:10.3390/cancers17020228 · Cited by 83
“These changes lead to the formation of an organized epithelial structure [71].”
The Breast Tumor Microenvironment: A Key Player in Metastatic Spread
Terceiro, L. E. L., Edechi, C. A., Ikeogu, N. M., Nickel, B. E., Hombach‐Klonisch, S., Sharif, T., Leygue, E., & Myal, Y. (2021) · Cancers · doi:10.3390/cancers13194798 · Cited by 81
“Some cancer cells have now been shown to possess a hybrid of epithelial and mesenchymal phenotypes which exhibit higher metastatic potential and chemoresistance compared to either “fully” epithelial or mesenchymal cancer cells (for review [77,78]).”
BackgroundThe many regulators of epithelial−mesenchymal transition
Bracken, C. P., & Goodall, G. J. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00442-x · Cited by 81
Self-citationSingle-cell RNA sequencing uncovers a neuron-like macrophage subset associated with cancer pain
Tang, P. C., Chung, J. Y., Liao, J., Chan, M. K., Chan, A. S. W., Cheng, G., Li, C., Huang, X., Ng, C. S. H., Lam, E. W. ‐., et al. (2022) · Science Advances · doi:10.1126/sciadv.abn5535 · Cited by 81
Cancer plasticity in therapy resistance: Mechanisms and novel strategies
Niu, X., Liu, W., Yinling, Z., Liu, J., Zhang, J., Li, B., Qiu, Y., Zhao, P., Wang, Z., & Wang, Z. (2024) · Drug Resistance Updates · doi:10.1016/j.drup.2024.101114 · Cited by 81
Self-citationXie, Y., Wang, X., Wang, W., Pu, N., & Liu, L. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06422-5 · Cited by 80
“Identifying and quantifying EMT remains challenging due to the lack of reliable biomarkers and the inherent complexity and fluidity of the process [178].”
Lymphatic metastasis of bladder cancer: Molecular mechanisms, diagnosis and targeted therapy
Liu, S., Chen, X., & Lin, T. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.02.010 · Cited by 80
Tyler, M. P. H., & Tirosh, I. (2021) · Nature Communications · doi:10.1038/s41467-021-22800-1 · Cited by 80
Harnessing epithelial-mesenchymal plasticity to boost cancer immunotherapy
Gu, Y., Zhang, Z., & ten Dijke, P. (2023) · Cellular and Molecular Immunology · doi:10.1038/s41423-023-00980-8 · Cited by 80
“In contrast, mesenchymal cells can reverse to epithelial cells through activating MET program. microRNAs such as miR-200 and miR-34 play important role in this process, which suppress EMT-TFs ZEB1/2 and Snail respectively to form a negative feedback (Fig.”
BackgroundInfluentialFan, C., Wang, Q., Kuipers, T. B., Cats, D., Iyengar, P. V., Hagenaars, S. C., Mesker, W. E., Devilee, P., Tollenaar, R. A. �. �., Mei, H., et al. (2023) · The EMBO Journal · doi:10.15252/embj.2022112806 · Cited by 79
TGF-β1 dominates stromal fibroblast-mediated EMT via the FAP/VCAN axis in bladder cancer cells
Ping, Q., Wang, C., Cheng, X., Zhong, Y., Yan, R., Yang, M., Shi, Y., Li, X., Li, X., Huang, W., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04303-3 · Cited by 79
“Epithelial cancer cells acquire migratory and invasive capabilities through both EMT and crosstalk with the tumor microenvironment (TME), including stromal cells, immune cells, cytokines, chemokines, inflammatory mediators, and extracellular matrix (ECM) [3, 4].”
BackgroundInfluentialDeterminants of renal cell carcinoma invasion and metastatic competence
Kim, K., Zhou, Q., Christie, A. L., Stevens, C., Ma, Y., Onabolu, O., Chintalapati, S., McKenzie, T., Tcheuyap, V. T., Woolford, L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25918-4 · Cited by 78
Circulating tumour cells in the -omics era: how far are we from achieving the ‘singularity’?
Visal, T. H., den Hollander, P., Cristofanilli, M., & Mani, S. A. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01768-9 · Cited by 79
“The gain of mesenchymal-like features enables cells to migrate from the primary tumour [34] and promotes their entry into the circulation [35, 36].”
BackgroundSelf-citationMLL3 loss drives metastasis by promoting a hybrid epithelial–mesenchymal transition state
Cui, J., Zhang, C., Lee, J., Bartholdy, B., Yang, D., Liu, Y., Erler, P., Galbo, P. M., Hodge, D. Q., Huangfu, D., et al. (2023) · Nature Cell Biology · doi:10.1038/s41556-022-01045-0 · Cited by 78
Yang, H., Yang, S., He, J., Li, W., Zhang, A., Li, N., Zhou, G., & Sun, B. (2023) · Cancer Cell International · doi:10.1186/s12935-023-03162-8 · Cited by 77
“According to the correlation analysis results, GLUT3 expression was positively correlated with the HALLMARK_EMT pathway and other classic EMT regulatory pathways (such as TGFβ, JAK_STAT3, WNT, and INTEGRIN_ACTIVITY) [19] (Fig.”
The YAP-TEAD complex promotes senescent cell survival by lowering endoplasmic reticulum stress
Anerillas, C., Mazan-Mamczarz, K., Herman, A. B., Munk, R., Lam, K.-W. G., Calvo-Rubio, M., Garrido, A., Tsitsipatis, D., Martindale, J. L., Altés, G., et al. (2023) · Nature Aging · doi:10.1038/s43587-023-00480-4 · Cited by 76
Zhao, N., Powell, R. T., Yuan, X., Bae, G., Roarty, K. P., Stossi, F., Strempfl, M., Toneff, M. J., Johnson, H. L., Mani, S. A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24545-3 · Cited by 77
Self-citationFerroptosis: Promising approach for cancer and cancer immunotherapy
Zheng, S., & Guan, X. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216152 · Cited by 76
Epithelial–Mesenchymal Transition Mechanisms in Chronic Airway Diseases: A Common Process to Target?
Mottais, A., Riberi, L., Falco, A., Soccal, S., Gohy, S. T., & Rose, V. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512412 · Cited by 76
“Epithelial-to-mesenchymal transition (EMT) is defined as a reversible cellular complex process, during which epithelial cells lose the classic epithelial markers, acquire a mesenchymal phenotype and are then able to produce extracellular matrix (ECM) [1].”
BackgroundPharmacological targeting of the cancer epigenome
Mabe, N. W., Perry, J. A., Malone, C. F., & Stegmaier, K. (2024) · Nature Cancer · doi:10.1038/s43018-024-00777-2 · Cited by 77
“It has long been observed that epithelial cancers can undergo an epithelial-to-mesenchymal transition, a state more resistant to cytotoxic, targeted and immunotherapies 190,191 .”
Song, X., An, Y., Chen, D., Zhang, W., Wu, X., Li, C., Wang, S., Dong, W., Wang, B., Liu, T., et al. (2021) · Cancer Science · doi:10.1111/cas.15208 · Cited by 75
Research on Gut Microbiota-Derived Secondary Bile Acids in Cancer Progression
Yang, R., & Li, Q. (2022) · Integrative Cancer Therapies · doi:10.1177/15347354221114100 · Cited by 75
Hypoxia-induced ROS aggravate tumor progression through HIF-1α-SERPINE1 signaling in glioblastoma
Zhang, L., Cao, Y., Guo, X., Wang, X., Han, X., Kanwore, K., Hong, X., Zhou, H., & Gao, D. (2023) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2200269 · Cited by 75
Epithelial–mesenchymal plasticity in kidney fibrosis
Hadpech, S., & Thongboonkerd, V. (2023) · genesis · doi:10.1002/dvg.23529 · Cited by 77
“For example, high glucose elevates intracellular ROS, induces cellular apoptosis, and promotes TIF (Ji et al., 2019; Yang et al., 2020).”
BackgroundInfluentialEtiology and Pathogenesis of Rheumatoid Arthritis-Interstitial Lung Disease
Kim, Y., Yang, H.-I., & Kim, K. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914509 · Cited by 75
“EMT is a cellular process in which epithelial cells acquire mesenchymal features while losing the epithelial features [133].”
BackgroundWang, D., Du, G., Chen, X., Wang, J., Liu, K., Zhao, H., Cheng, C., He, Y., Jing, N., Xu, P., et al. (2024) · Cell Death and Differentiation · doi:10.1038/s41418-024-01295-5 · Cited by 75
Cell polarity changes in cancer initiation and progression
Péglion, F., & Etienne‐Manneville, S. (2023) · The Journal of Cell Biology · doi:10.1083/jcb.202308069 · Cited by 74
“For more information, the reader is referred to the guidelines written by the EMT International Association (Yang et al., 2020). alteration can also promote EMT by affecting the level of EMT-inhibiting intracellular miRNA.”
BackgroundEGFR as a stable marker of prostate cancer dissemination to bones
Nastały, P., Stoupiec, S., Popęda, M., Smentoch, J., Schlomm, T., Morrissey, C. M., Zaczek, A. J., Beyer, B., Tennstedt, P., Graefen, M., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01052-8 · Cited by 75
Zheng, X., Yu, C., & Xu, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.678333 · Cited by 73
Regulation of Partial and Reversible Endothelial-to-Mesenchymal Transition in Angiogenesis
Fang, J. S., Hultgren, N. W., & Hughes, C. C. W. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.702021 · Cited by 74
The effects of epithelial–mesenchymal transitions in COPD induced by cigarette smoke: an update
Su, X., Wu, W., Zhu, Z., Lin, X., & Zeng, Y. (2022) · Respiratory Research · doi:10.1186/s12931-022-02153-z · Cited by 73
“Epithelial–mesenchymal transformation (EMT) is a unique biological process in which epithelial cells lose their polarity and transform into mobile mesenchymal cells [7].”
BackgroundMorphological and cytoskeleton changes in cells after EMT
Nurmagambetova, A., Mustyatsa, V. V., Saidova, A. A., & Vorobjev, I. A. (2023) · Scientific Reports · doi:10.1038/s41598-023-48279-y · Cited by 73
Punovuori, K., Bertillot, F., Miroshnikova, Y. A., Binner, M., Myllymäki, S.-M., Follain, G., Kruse, K., Routila, J., Huusko, T., Pellinen, T. S., et al. (2024) · Cell · doi:10.1016/j.cell.2024.09.046 · Cited by 73
Mechanisms of Cisplatin Resistance in HPV Negative Head and Neck Squamous Cell Carcinomas
Griso-Acevedo, A. B., Acero-Riaguas, L., Castelo, B., Carretero, J. L. C., & Sastre-Perona, A. (2022) · Cells · doi:10.3390/cells11030561 · Cited by 73
“Although these processes have been identified and well-described in vitro, the identification of cancer cells with full EMT characteristics in patient specimens has failed [92].”
BackgroundHuh, H. D., Sub, Y., Oh, J., Kim, Y. E., Lee, J. Y., Kim, H.-R., Lee, S., Lee, H., Pak, S., Amos, S. E., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01753-7 · Cited by 72
“…of epithelial-to-mesenchymal transition (EMT) in various biological context, including embryogenesis, wound healing, and tumor progression [3], that guides the morphological transition between epithelial (E), and mesenchymal (M) phenotypes, both of which are adherent (A) cell types with…”
BackgroundAngarola, B. L., Sharma, S. M., Katiyar, N., Kang, H. G., Nehar-Belaid, D., Park, S., Gott, R., Eryilmaz, G. N., LaBarge, M. A., Palucka, K., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00751-8 · Cited by 73
Metastasis: crosstalk between tissue mechanics and tumour cell plasticity
Coban, B., Bergonzini, C., Zweemer, A. J. M., & Danen, E. H. J. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01150-7 · Cited by 71
Context-dependent TGFβ family signalling in cell fate regulation
Richardson, L., Wilcockson, S. G., Guglielmi, L., & Hill, C. S. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00638-3 · Cited by 72
“Signal-ling through both TGFBRI–SMAD3/4 and ACVRI–SMAD1/5/4 pathway arms induces the expression of master regulators of EMT including SNAIL1, SNAIL2, ZEB and TWIST, which repress epithelial identity and promote mesenchymal phenotypes 24,165 .”
BackgroundInfluentialVitamin D Effects on Cell Differentiation and Stemness in Cancer
Fernández‐Barral, A., Bustamante‐Madrid, P., Ferrer‐Mayorga, G., Barbáchano, A., Larriba, M. J., & Múñoz, A. (2020) · Cancers · doi:10.3390/cancers12092413 · Cited by 71
“As a result, epithelial cells remodel their cytoskeletons, lose cell–cell and cell–ECM adhesion, change to a front–back polarity and acquire a fibroblastic-like phenotype with motility and basal membrane invasion capacities [11,12].”
BackgroundThe CXCL12 Crossroads in Cancer Stem Cells and Their Niche
López-Gil, J. C., Martín-Hijano, L., Hermann, P. C., & Sáinz, B. (2021) · Cancers · doi:10.3390/cancers13030469 · Cited by 70
Exosomal-long non-coding RNAs journey in colorectal cancer: Evil and goodness faces of key players
Rizk, N. I., Abulsoud, A. I., Kamal, M. M., Kassem, D. H., & Hamdy, N. Μ. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120325 · Cited by 70
Syndecan-1 (CD138), Carcinomas and EMT
Couchman, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084227 · Cited by 70
Kvokačková, B., Remšík, J., Jolly, M. K., & Souček, K. (2021) · Cancers · doi:10.3390/cancers13092188 · Cited by 70
“Owing to the transient and dynamic nature of EMT/MET during invasion, dissemination, and metastatic outgrowth, a growing body of evidence suggests that EMP in cancer cells is fueled by the external microenvironmental cues from primary TME or pre-existing metastatic niche, rather than driven by the cell-intrinsic genet…”
BackgroundInfluentialKhanbabaei, H., Ebrahimi, S., García‐Rodríguez, J. L., Ghasemi, Z., Pourghadamyari, H., Mohammadi, M., & Kristensen, L. S. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02488-x · Cited by 70
“These changes confer attributes of ‘high-grade malignancy’ on carcinoma cells, including motility, invasive behavior, cancer stem cell (CSC)-properties, resistance to conventional therapies and immunoevasive and immunosuppressive features [2].”
BackgroundWnt/β-catenin signaling in the development and therapeutic resistance of non-small cell lung cancer
Zhang, Z., Westover, D., Tang, Z., Liu, Y., Sun, J., Sun, Y., Zhang, R., Wang, X., Zhou, S., Hesilaiti, N., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05380-8 · Cited by 69
“During the early phase of EMT, loss of apical–basal polarity is often the first event to be observed and can lead to the destabilization of adhesion complexes, including AJs at the lateral membrane [13].”
BackgroundEpigenetic regulation of cancer stemness
Galassi, C., Manic, G., Esteller, M., Galluzzi, L., & Vitale, I. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02340-6 · Cited by 69
Metadata
- Authors
- Yang, J., Antin, P., Berx, G., Blanpain, C., Brabletz, T., Bronner, M., Campbell, K., Cano, A., Casanova, J., Christofori, G., Dedhar, S., Derynck, R., Ford, H. L., Fuxe, J., García de Herreros, A., Goodall, G. J., Hadjantonakis, A.-K., Huang, R. Y. J., Kalcheim, C., Kalluri, R., Kang, Y., Khew-Goodall, Y., Levine, H., Liu, J., Longmore, G. D., Mani, S. A., Massagué, J., Mayor, R., McClay, D., Mostov, K. E., Newgreen, D. F., Nieto, M. A., Puisieux, A., Runyan, R., Savagner, P., Stanger, B., Stemmler, M. P., Takahashi, Y., Takeichi, M., Theveneau, E., Thiery, J. P., Thompson, E. W., Weinberg, R. A., Williams, E. D., Xing, J., Zhou, B. P., Sheng, G., & On behalf of the EMT International Association (TEMTIA)
- Affiliations
- University of California San Diego (US)
- University of Arizona (US)
- Ghent University (BE)
- Université Libre de Bruxelles (BE)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- University of Sheffield (GB)
- Instituto de Investigaciones Biomédicas Sols-Morreale (ES)
- Consejo Superior de Investigaciones Científicas (ES)
- University of Basel (CH)
- University of British Columbia (CA)
- University of California, San Francisco (US)
- University of Colorado Anschutz (US)
- Karolinska University Hospital (SE)
- South Australia Pathology (AU)
- Memorial Sloan Kettering Cancer Center (US)
- National Taiwan University (TW)
- Hebrew University of Jerusalem (IL)
- The University of Texas MD Anderson Cancer Center (US)
- Princeton University (US)
- Northeastern University (US)
- Washington University in St. Louis (US)
- University College London (GB)
- Duke University (US)
- Royal Children's Hospital (AU)
- Instituto de Neurociencias (ES)
- Lyon 1 Université (FR)
- Inserm (FR)
- University of Pennsylvania (US)
- Kyoto University (JP)
- RIKEN Center for Biosystems Dynamics Research (JP)
- Guangzhou Regenerative Medicine and Health Guangdong Laboratory (CN)
- Translational Research Institute (AU)
- Whitehead Institute for Biomedical Research (US)
- Queensland University of Technology (AU)
- University of Pittsburgh (US)
- University of Kentucky (US)
- International Research Center for Medical Sciences, Kumamoto University (JP)
- Corresponding author
- Yang, Jing
- Sheng, Guojun
- ORCID
- Yang, Jing
- Antin, Parker
- Berx, Geert
- Blanpain, Cédric
- Brabletz, Thomas
- Campbell, Kyra
- Casanova, Jordi
- Christofori, Gerhard
- Dedhar, Shoukat
- Derynck, Rik
- Ford, Heide L.
- Fuxe, Jonas
- Goodall, Gregory J.
- Hadjantonakis, Anna-Katerina
- Huang, Ruby Y. J.
- Kalcheim, Chaya
- Kalluri, Raghu
- Kang, Yibin
- Levine, Herbert
- Liu, Jinsong
- Longmore, Gregory D.
- Mani, Sendurai A.
- Massagué, Joan
- Mayor, Roberto
- McClay, David
- Mostov, Keith E.
- Newgreen, Donald F.
- Nieto, M. Angela
- Puisieux, Alain
- Runyan, Raymond
- Savagner, Pierre
- Stanger, Ben
- Stemmler, Marc P.
- Takahashi, Yoshiko
- Takeichi, Masatoshi
- Theveneau, Eric
- Thiery, Jean Paul
- Thompson, Erik W.
- Weinberg, Robert A.
- Williams, Elizabeth D.
- Xing, Jianhua
- Zhou, Binhua P.
- Sheng, Guojun
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2020-04-16
- Volume
- 21
- Issue
- 6
- Pages
- 341-352
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- PMC
- PMC7250738
- OpenAlex
- W3016840787
- Cited by
- 2,226
- References
- 139
- Citations by year
- 2026: 249 · 2025: 382 · 2024: 403 · 2023: 396 · 2022: 386 · 2021: 313 · 2020: 88
- FWCI
- 32.46
- Type
- journal article
- Language
- en
- Update notices
- correction (2021-10-15)
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by)
- QUT ePrints (Queensland University of Technology) (submittedVersion, cc-by)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion, cc-by)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Biblos-e Archivo (Universidad Autónoma de Madrid) (submittedVersion, public-domain)
- CaltechAUTHORS (California Institute of Technology) (submittedVersion, cc-by)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion, cc-by)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion, other-oa)
- eScholarship (California Digital Library) (submittedVersion)
- Hispana (submittedVersion)
- Repositori digital de la UPF (Universitat Pompeu Fabra) (submittedVersion, cc-by)
- Funders
- Wellcome Trust (204615/Z/16/Z)
- Biotechnology and Biological Sciences Research Council (BB/R00627X/1, BB/T013044/1)
- Japan Society for the Promotion of Science (19H04775, 20K21425, 18H02452, 20K20520, 16KT0071)
- National Cancer Institute (R01CA223758, R37CA232209, P30CA023100, P30CA016672)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK119232)
- National Institute of Environmental Health Sciences (P30ES006694)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P41HD088362)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- epithelial-mesenchymal transition, nomenclature, research guidelines, cell migration, cell invasion, transcription factors, cancer, developmental processes
- MeSH terms
- Cell Plasticity, Animals, Cell Movement, Humans, Neoplasms, Terminology as Topic, Developmental Biology, Consensus, Biomedical Research, Epithelial-Mesenchymal Transition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.